Cargando…

Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease

Recent studies reported an association between gut microbiota composition and Parkinson’s disease (PD). However, we know little about the relationship between microbiome dysbiosis and the pathogenesis of PD. The objective of this study was to describe the evolution of fecal microbiota using an oral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xiaodong, Qian, Yiwei, Xu, Shaoqing, Song, Yanyan, Xiao, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766661/ https://www.ncbi.nlm.nih.gov/pubmed/29358918 http://dx.doi.org/10.3389/fnagi.2017.00441

Ejemplares similares

Hypermethylation of the Gene Coding for PGC-1α in Peripheral Blood Leukocytes of Patients With Parkinson’s Disease
por: Yang, Xiaodong, et al.
Publicado: (2020)

Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson’s Disease
por: Qian, Yiwei, et al.
Publicado: (2018)

Corrigendum: Detection of Microbial 16S rRNA Gene in the Blood of Patients With Parkinson's Disease
por: Qian, Yiwei, et al.
Publicado: (2019)

Progression of Parkinson's Disease Pathology Is Reproduced by Intragastric Administration of Rotenone in Mice
por: Pan-Montojo, Francisco, et al.
Publicado: (2010)

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023)

Rotenone aggravates PD-like pathology in A53T mutant human α-synuclein transgenic mice in an age-dependent manner
por: Chen, An-Di, et al.
Publicado: (2022)

Rotenone, Paraquat, and Parkinson’s Disease
por: Tanner, Caroline M., et al.
Publicado: (2011)

Overexpression of Mitochondrial Ligases Reverses Rotenone-Induced Effects in a Drosophila Model of Parkinson’s Disease
por: Doktór, Bartosz, et al.
Publicado: (2019)

The Impairments of α-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson’s Disease
por: Ramalingam, Mahesh, et al.
Publicado: (2019)

Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model
por: Magdy, Alshimaa, et al.
Publicado: (2022)

Roles of functional catechol-O-methyltransferase genotypes in Chinese patients with Parkinson’s disease
por: Xiao, Qin, et al.
Publicado: (2017)

Autophagy Disruptions Associated With Altered Optineurin Expression in Extranigral Regions in a Rotenone Model of Parkinson's Disease
por: Wise, John P., et al.
Publicado: (2018)

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
por: Liu, Lan-Xiang, et al.
Publicado: (2018)

Enriched Environmental Conditions Modify the Gut Microbiome Composition and Fecal Markers of Inflammation in Parkinson’s Disease
por: Singh, Yogesh, et al.
Publicado: (2019)

Intermittent Fasting Applied in Combination with Rotenone Treatment Exacerbates Dopamine Neurons Degeneration in Mice
por: Tatulli, Giuseppe, et al.
Publicado: (2018)

Non-Reproducibility of Oral Rotenone as a Model for Parkinson’s Disease in Mice
por: Niederberger, Ellen, et al.
Publicado: (2022)

Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: Fathalla, Ahmed M., et al.
Publicado: (2016)

Effect of Acute Levodopa Up-Titration on Blood Pressure in Patients With Early Stage Parkinson’s Disease: Results of a Levodopa Challenge Test
por: He, Xiaoqin, et al.
Publicado: (2022)

Olfactory impairment in the rotenone model of Parkinson’s disease is associated with bulbar dopaminergic D2 activity after REM sleep deprivation
por: Rodrigues, Lais S., et al.
Publicado: (2014)

Commentary: Adenosine A(2A) Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism
por: de Souza, Marina F., et al.
Publicado: (2017)

Adult health and transition stage-specific rotenone-mediated Drosophila model of Parkinson’s disease: Impact on late-onset neurodegenerative disease models
por: Ayajuddin, Mohamad, et al.
Publicado: (2022)

Huangqin Decoction Exerts Beneficial Effects on Rotenone-Induced Rat Model of Parkinson's Disease by Improving Mitochondrial Dysfunction and Alleviating Metabolic Abnormality of Mitochondria
por: Gao, Li, et al.
Publicado: (2022)

Anti-inflammatory and Anti-oxidant Activity of Hidrox(®) in Rotenone-Induced Parkinson’s Disease in Mice
por: Siracusa, Rosalba, et al.
Publicado: (2020)

Taste Impairments in a Parkinson’s Disease Model Featuring Intranasal Rotenone Administration in Mice
por: Yin, Dong Xu, et al.
Publicado: (2022)

The role of autophagy in Parkinson's disease: rotenone-based modeling
por: Xiong, Nian, et al.
Publicado: (2013)

Piracetam and vinpocetine ameliorate rotenone-induced Parkinsonism in rats
por: Zaitone, Sawsan A., et al.
Publicado: (2012)

Valeriana officinalis Counteracts Rotenone Effects on Spreading Depression in the Rat Brain in vivo and Protects Against Rotenone Cytotoxicity Toward Rat Glioma C6 Cells in vitro
por: Amaral de Brito, Ana Paula, et al.
Publicado: (2020)

Monoterpenoid Epoxidiol Ameliorates the Pathological Phenotypes of the Rotenone-Induced Parkinson’s Disease Model by Alleviating Mitochondrial Dysfunction
por: Aleksandrova, Yulia, et al.
Publicado: (2023)

Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson's disease model rats★
por: Li, Chun, et al.
Publicado: (2012)

Ndfip1 Prevents Rotenone-Induced Neurotoxicity and Upregulation of α-Synuclein in SH-SY5Y Cells
por: Liu, Xin, et al.
Publicado: (2021)

Plasma branched-chain and aromatic amino acids correlate with the gut microbiota and severity of Parkinson’s disease
por: Zhang, Yi, et al.
Publicado: (2022)

Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease
por: Arnhold, Mike, et al.
Publicado: (2016)

The effect of low dose amphetamine in rotenone-induced toxicity in a mice model of Parkinson’s disease
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2020)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra
por: Huang, Chun, et al.
Publicado: (2017)

Neuroprotective potential of ferulic acid in the rotenone model of Parkinson’s disease
por: Ojha, Shreesh, et al.
Publicado: (2015)

Findings in Chinese Patients With Parkinson's Disease: A Content Analysis From the SML Study
por: Qian, Yiwei, et al.
Publicado: (2021)

The Role of the Intestinal Microbiome in Chronic Psychosocial Stress-Induced Pathologies in Male Mice
por: Langgartner, Dominik, et al.
Publicado: (2018)

Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies
por: Lubomski, Michal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ftdcp09b6pv9spdrkbv15liir0